GI Web Banner.jpg

Vanderbilt has a long-standing reputation as a leader in treating digestive disorders. As part of one of the nation's elite medical centers, we offer world-class comprehensive care featuring pioneering research, highly trained providers, and a dedicated staff.

Our state-of-the-art diagnostic and treatment center uses the most advanced techniques and technology available. Highly specialized physicians and advanced nurse practitioners lead the way in diagnosing and treating digestive disorders. We work with other specialists at Vanderbilt to find the best treatments for our patients and offer them complete care to cover every aspect of their disease.

New to Vanderbilt?

Before registering for a clinical trial, it is important to establish care with one of the doctors in our clinic. In order to provide you with the best possible care, our doctors will check your medical history and evaluate the current state of your disease. By doing so, we can help assist you in your decision to participate in a trial and decide which one is right for you. Click the link below to learn about becoming a Vanderbilt patient. From there, select "request an appointment" to get started!

Become a patient rect.jpg


Current Trials and centers yellow.jpg   FAQ.jpg


Resources Rect.jpg   Donate body to research rect.jpg


Featured Study

Title: A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Patients Who Are Refractory to or Intolerant of TNF Inhibitors
(GA28950 - Hickory)

Study Contact: Erin Landry 615-322-4573   
Principal Investigator: David A. Schwartz, MD

This phase III, double blind, placebo-controlled, multicenter study will investigate the efficacy and safety of etrolizumab during induction and maintenance of remission in patients with moderately to severely active ulcerative colitis (UC) who are refractory to or intolerant of tumor necrosis factor (TNF) inhibitors.

Click here for more information on this study


Vanderbilt GI Clinical Trials